| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2011-03-29 | Lu AF11167 | Parkinson's disease | 1 | Lundbeck (Denmark) | Neurodegenerative diseases - CNS diseases |
| 2011-03-22 | BT-061 | rheumatoid arthritis | 2 | Biotest (Germany) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2011-03-21 | FluGEM® (novel improved influenza vaccine for the elderly) | influenza | 1 | Mucosis (The Netherlands) | Infectious diseases |
| 2011-03-21 | PF-04523655 (RTP801I-14) | diabetic macular edema | 2b | Quark Pharmaceuticals (USA) Silence Therapeutics (UK) | Ophtalmological diseases |
| 2011-03-20 | vismodegib | advanced basal cell carcinoma | 2 | Genentech, a member of the Roche group (USA - Switzerland) | Cancer - Oncology |
| 2011-03-17 | SAF-301 | Sanfilippo disease (Mucopolysaccharidosis type IIIA) | 1-2 | Lysogene (France) | Rare diseases - Genetic diseases |
| 2011-03-16 | talactoferrin | non-small cell lung cancer | 3 | Agennix (Germany) | Cancer - Oncology |
| 2011-03-16 | V158866 (fatty acid amide hydrolase (FAAH) inhibitor) | pain and other indications | Vernalis (UK) | CNS diseases | |
| 2011-03-15 | NKTR-118 (oral peripherally-acting opioid antagonist)This once-daily oral tablet combines Nektar\'s advanced small molecule polymer conjugate technology platform with naloxol, a derivative of the opioid antagonist drug, naloxone. | opioid-induced constipation | 3 | AstraZeneca (UK) | Digestive diseases |
| 2011-03-15 | INC424 (ruxolitinib) | myelofibrosis | 3 | Novartis (Switzerland) | Cancer - Oncology - Blood diseases |
| 2011-03-15 | HinsBet® (fast-acting human insulin) | type 1 diabetes | 1 | Adocia (France) | Metabolic diseases |
| 2011-03-15 | ICX-RHY | Recessive Dystrophic Epidermolysis Bullosa (RDEB) |
2 | King’s College London (UK) Intercytex (UK) DEBRA (UK) | Rare diseases - Genetic diseases - Dermatological diseases |
| 2011-03-14 | IPX066 (investigational carbidopa-levodopa (CD-LD) product with an enhanced pharmacokinetic profile) | Parkinson's disease |
3 | GSK (UK) Impax Pharmaceuticals (USA - CA) | Neurodegenerative diseases - CNS diseases |
| 2011-03-14 | GLPG0187 | metastatic cancer |
1b | Galapagos (Belgium) | Cancer - Oncology |
| 2011-03-14 | belinostat | non-small cell lung cancer | 1-2 | Topotarget (Denmark) Spectrum Pharmaceuticals (USA) | Cancer- Oncology |
| 2011-03-14 | belinostat | ovarian cancer non small cell lung cancer (NSCLC) |
2 | Topotarget (Denmark) | Cancer - Oncology |
| 2011-03-11 | otelixizumab (humanised anti-CD3 monoclonal antibody) | diabetes |
3 | GSK (UK) ToleRX (USA) | Metabolic diseases |
| 2011-03-10 | cardiotrophin-1 | prevention of delayed graft function |
1 | Digna Biotech (Spain) Biotecnol (Portugal) | Transplantation |
| 2011-03-10 | aflibercept (VEGF Trap) | non-small cell lung cancer (NSCLC) | 3 | Sanofi-Aventis (France) Regeneron Pharmaceuticals (USA) | Cancer - Oncology |
| 2011-03-09 | ND0611 Dermal Patch | Parkinson’s disease | 2 | NeuroDerm (Israel) | Neurodegenerative diseases - CNS diseases |
